Jensa Morris: Anticoagulation in Thrombocytopenia and Cancer-Associated Thrombosis
Jensa Morris, Director of Smilow Hospitalist Service at Yale New Haven Hospital, shared a post on LinkedIn about a recent article by Tzu–Fei Wang et al, published in RPTH, adding:
“Anticoagulation of Patients with Acute VTE and Thrombocytopenia
This is a dilemma we frequently encounter on the Oncololgy Hospitalist service.
The intersection of thrombocytopenia and a hypercoagulable state creates a complex clinical scenario.
Even mild thrombocytopenia in the setting of anticoagulation increases bleeding risk and yet is not protective against thrombosis.
Current management recommendations are guided by expert International Society on Thrombosis and Haemostasis (ISTH) consensus rather than robust clinical trial data:
- Platelet count 50K or higher means full-dose anticoagulation
- Platelet count below 50K and high risk (e.g., PE or acute symptomatic proximal DVT) means full-dose anticoagulation with platelet transfusion to target 40–50K
- Platelets 25–50K and lower risk (incidental PE, CRT, distal DVT) means half-dose LMWH
- Platelets below 25K means temporarily hold anticoagulation
To address this knowledge gap, the START (STrategies for Anticoagulation in patients with thRombocytopenia and cancer associated Thrombosis) pilot feasibility trial is now enrolling.
Looking forward to results to guide this frequent clinical problem.”
Title: Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trial
Authors: Tzu–Fei Wang, Mari Thomas, Andrea Cervi, Yishi Tan, Cynthia Wu, Avi Leader, Luis Jara–Palomares, Simon J. Stanworth, Marc Carrier
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation